Arkolith/Insider Trading/TMCI/Form 4

Treace John T.

Chief Executive Officer, Director, 10% OwnerTREACE MEDICAL CONCEPTS, INC. (TMCI) · full profile →Form 4 · filed Mar 11, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 10, 2025Tax withholding(F)5K—$06.8M
Mar 8, 2025Tax withholding(F)2K—$06.8M

Transaction Codes

F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-037574) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML